306
Participants
Start Date
November 1, 2021
Primary Completion Date
January 31, 2022
Study Completion Date
February 2, 2022
Nitric Oxide
The Sponsor designed a dual chamber nasal spray bottle for NORS administration. Components are mixed from two chambers to create the final NO-producing formulation. The liquid contains NO at 0.11 ppm\*hour, which acts as a viricidal agent. Instructions for storing, preparing, and administering the study treatment will be provided to participants.
Maharaja Agrasen Superspeciality Hospital, Jaipur
St. Georges Hospital, Mumbai
Dr Rahul Kodgule, Mumbai
Orchid Specialty Hospital, Lohgaon
Lifepoint Multispeciality Hospital, Pune
Prakash Institute of Medical Sciences & Research, Islāmpur
Pharmacology Dept. CPR Hospital Campus, Town Hall,, Kolhāpur
Ishwar Institute & Hospital, Aurangabad
MGM Medical College & Hospital, Aurangabad
Government Medical College and Hospital Nagpur, Nagpur
All India Institute of Medical Sciences, Nagpur
St.Theresas Hospital, Hyderabad
Aster Prime Hospital, Hyderabad
Bangalore Medical College and Research Institute, Bangalore
Hindusthan Hospital, Coimbatore
Malabar Medical College Hospital and Research Centre, Kozhikode
C K Birla Hospitals, The Calcutta Medical Research Institute, Kolkata
Peerless Hospitex Hospital And Research Centre Limited, Kolkata
Marwari Hospital, Guwahati
Renova Neelima Hospitals, Hyderabad
CSI Medical College and Hospital, Kolkata
Collaborators (1)
Glenmark Pharmaceuticals Ltd. India
INDUSTRY
Sanotize Research and Development corp.
INDUSTRY